6256-96-8 Usage
Uses
Used in Organic Synthesis:
2,5,6-trifluoropyridine-3,4-diaMine is utilized as a key intermediate in organic synthesis for the development of various chemical compounds. Its presence of fluorine atoms and a diamine group allows for a range of chemical reactions, enabling the synthesis of novel molecules with potential applications in different fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2,5,6-trifluoropyridine-3,4-diaMine is employed as a building block for the creation of new drug candidates. Its unique structure and functional groups can be leveraged to design molecules with specific biological activities, potentially leading to the discovery of new therapeutic agents. 2,5,6-trifluoropyridine-3,4-diaMine's reactivity and versatility make it a promising starting point for the development of innovative pharmaceuticals.
Used in Medicinal Chemistry:
2,5,6-trifluoropyridine-3,4-diaMine is also used in medicinal chemistry as a scaffold for the design and optimization of bioactive molecules. Its structural features can be modified to enhance the potency, selectivity, and pharmacokinetic properties of drug candidates, contributing to the advancement of new treatments for various diseases and conditions.
Used in Agrochemical Development:
In the agrochemical sector, 2,5,6-trifluoropyridine-3,4-diaMine can be used as a starting material for the synthesis of novel pesticides, herbicides, or insecticides. Its chemical properties and reactivity can be harnessed to create compounds with improved efficacy, selectivity, and environmental compatibility.
Used in Material Science:
2,5,6-trifluoropyridine-3,4-diaMine may also find applications in material science, where it can be incorporated into the design of new materials with specific properties. Its fluorine atoms and diamine functional group can contribute to the development of materials with unique electronic, optical, or mechanical characteristics, potentially leading to innovative applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 6256-96-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,5 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6256-96:
(6*6)+(5*2)+(4*5)+(3*6)+(2*9)+(1*6)=108
108 % 10 = 8
So 6256-96-8 is a valid CAS Registry Number.
6256-96-8Relevant academic research and scientific papers
Novel nucleosides and related processes, pharmaceutical compositions and methods
-
Page/Page column 13; Figure 2, (2010/02/07)
The invention provides novel nucleosides and related processes, pharmaceutical compositions, and methods. The novel nucleosides are useful in a wide variety of antiviral, antineoplastic, and antibacterial applications. Preferred embodiments of the instant invention include novel 2 halogen-substituted, 3 halogen-substituted, and 2′,3′dihalogen-substituted analogues of 3-deazaadenosine, and novel 3 halogen-substituted analogues of 3-deazaguanosine. Compounds of the instant invention, including 4-Amino-6-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine and 6-Amino-7-bromo-1,5-dihydro-1-β-D-ribofuranosylimidazo[4,5-c]pyridin-4-one, have exhibited potent antiviral and anticancer activity in vitro. The compounds are also useful in the concomitant treatment of bacterial infections associated with viral infections such as AIDS.
Synthesis of halogen-substituted 3-deazaadenosine and 3-deazaguanosine analogues as potential antitumor/antiviral agents
Liu,Luo,Mozdziesz,Lin,Dutschman,Gullen,Cheng,Sartorelli
, p. 1975 - 2000 (2007/10/03)
Various 2-halogen-substituted analogues (38, 39, 43 and 44), 3-halogensubstituted analogues (51 and 52), and 2′,3′ -dihalogen- substituted analogues (57-60) of 3-deazaadenosine and 3-halogen-substituted analogues (61 and 62) of 3-deazaguanosine have been synthesized as potential anticancer and/or antiviral agents. Among these compounds, 3-deaza-3-bromoguanosine (62) showed significant cytotoxicity against L1210, P388, CCRF-CEM and B16F10 cell lines in vitro, producing IC50 values of 3, 7, 9 and 7μM, respectively. Several 3-deazaadenosine analogues (38, 51, 57 and 59) showed moderate to weak activity against hepatitis B virus.
